Intravenous Vesicular Stomatitis Virus in Patients With Peripheral T-cell Lymphoma | MicrobiomeTrials← Back to trialsNCT06508463
Intravenous Vesicular Stomatitis Virus in Patients With Peripheral T-cell Lymphoma
RecruitingPHASE1INTERVENTIONAL
Trial Details
Start: 2024-01-05Est. Completion: 2028-12-31
Enrollment target: 21 participants Locations- Mayo Clinic in Arizona, Scottsdale, Arizona, United States
- Mayo Clinic in Rochester, Rochester, Minnesota, United States
Other microbiome trials you might be interested in
PTCLNK T-Cell Lymphoma
This is a randomized, open-label, multicenter Phase III study evaluating the efficacy and safety of TR115, an EZH2 inhib…
Beijin, ChinaEst. completion Jul 30, 2029
Acute Lymphoblastic Leukemia
This is a prospective specimen collection study evaluating the feasibility of using the ChromoSeq® assay for upfront cla…
St Louis, United StatesEst. completion Jul 15, 2028
Phase 1
Recruiting
Acute Lymphoblastic LeukemiaImmune System DiseasesImmunoproliferative Disorders
The body has different ways of fighting infection and disease. No single way is effective at fighting cancer. This resea…
Chapel Hill, United StatesEst. completion Sep 12, 2025